Evidence map›Paper›PMID 22663298›Full record

ArticleJournal of proteome research2012

Identification and validation of inhibitor-responsive kinase substrates using a new paradigm to measure kinase-specific protein phosphorylation index.

Xiang Li, Varsha Rao, Jin Jin, Bin Guan, Kenna L Anderes, Charles J Bieberich

Open access · greenAbstract read
In one paragraph

Article in Journal of proteome research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiang LiDepartment of Biological Sciences, University of Maryland Baltimore County, Baltimore, Maryland, USA.
Varsha Rao
Jin Jin
Bin Guan
Kenna L Anderes
Charles J Bieberich
University of Maryland, Baltimore County · USIncell Corporation (United States) · US

Funding

An Innovative Approach for Profiling Protein Kinase SubstratesR21CA122884 · NCI · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI BIEBERICH, CHARLES J. · 2007 to 2009
$388k
Application of an Innovative Technology to Develop Low Toxicity Kinase InhibitorsR21CA155568 · NCI · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI BIEBERICH, CHARLES J. · 2011 to 2012
$333k
NCI NIH HHS R21 CA122884NCI NIH HHS R21CA122884NCI NIH HHS R21 CA155568NCI NIH HHS R21CA155568
6 · The paper itself

Abstract

Regulation of all cellular processes requires dynamic regulation of protein phosphorylation. We have developed an unbiased system to globally quantify the phosphorylation index for substrates of a specific kinase by independently quantifying phosphorylated and total substrate molecules in a reverse in-gel kinase assay. Non-phosphorylated substrate molecules are first quantified in the presence and absence of a specific stimulus. Total substrate molecules are then measured after complete chemical dephosphorylation, and a ratio of phosphorylated to total substrate is derived. To demonstrate the utility of this approach, we profiled and quantified changes in phosphorylation index for Protein Kinase CK2 substrates that respond to a small-molecule inhibitor. A broad range of inhibitor-induced changes in phosphorylation was observed in cultured cells. Differences among substrates in the kinetics of phosphorylation change were also revealed. Comparison of CK2 inhibitor-induced changes in phosphorylation in cultured cells and in mouse peripheral blood lymphocytes in vivo revealed distinct kinetic and depth-of-response profiles. This technology provides a new approach to facilitate functional analyses of kinase-specific phosphorylation events. This strategy can be used to dissect the role of phosphorylation in cellular events, to facilitate kinase inhibitor target validation studies, and to inform in vivo analyses of kinase inhibitor drug efficacy.

Indexed as

Protein Processing, Post-TranslationalAnimalsCasein Kinase IIChromatography, AffinityFemaleHeLa CellsHumansLeukocytes, MononuclearMiceMolecular ChaperonesNaphthyridinesPhenazinesPhosphoproteinsPhosphorylationProstaglandin-E SynthasesProteomeCasein Kinase IIMolecular ChaperonesNaphthyridinesPhenazinesPhosphoproteinsProstaglandin-E SynthasesProteomePTGES3 protein, humansilmitasertib

Identifiers

PMID22663298
PMCPMC4133982
OpenAlexW2058913836

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.